- Home
- BCAB vs MGRX Comparison
BCAB vs MGRX Comparison
Compare BCAB & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | MGRX |
|---|---|---|
| Founded | 2007 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 7.1M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BCAB | MGRX |
|---|---|---|
| Price | $3.67 | $0.36 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 48.4K | ★ 590.8K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.86 | ★ 55.17 |
| EPS | N/A | ★ N/A |
| Revenue | $300,000.00 | ★ $456,021.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.12 | $0.26 |
| 52 Week High | $6.52 | $2.75 |
Technical Indicators
Market Signals| Indicator | BCAB | MGRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 49.14 |
| Support Level | $3.24 | $0.34 |
| Resistance Level | $6.33 | $0.49 |
| Average True Range (ATR) | 0.37 | 0.04 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 45.46 | 72.02 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs. The company's operations are organized on a single reportable segment, which includes all activities related to the discovery, development, and commercialization of its CAB products.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.